Unable to produce much-needed vaccines with its limited production capacity, Merck decided to rapidly increase its manufacturing capabilities.
When designing pharmaceutical facilities, there is much to be taken into consideration, and merely throwing up a "bunch of bricks" just doesn't cut it anymore.
The main ingredient in the male baldness treatment Propecia is responsible, the FDA says, for side effects that linger after patients stop taking the drug.
The world's biggest biotech drugmaker will help KAI finish planning late stage trials of its most advanced drug candidate, which helps dialysis patients.
Medical device maker Cook Group has bought an Indianapolis company that specializes in cell and tissue processing and cryopreservation technologies.
The vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S.
Medical device maker Medtronic Inc. has agreed to pay $85 million to resolve a federal class action lawsuit brought by a group of shareholders.
Swiss pharmaceutical company raised its offer for Illumina to $51 cash per share, in a bid to speed up a takeover of the U.S. diagnostics company.
In a recent test, the popular wrinkle remover and spasm suppressant worked better than a placebo as a treatment for an overactive bladder.
The government alleges that a Cypress subsidiary falsely claimed that three skin products carried the FDA's "safe and effective" designation.
An attorney has asked jurors to hold a J&J subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.
The first two trials of more than 2,400 lawsuits nationwide accuse the drug, which was made by Pfizer, of causing the patient to commit suicide.
The FDA asked the Mountain View, Calif.-based company to address "observations from a recent facility inspection of a third party manufacturer."
Eye-health company Bausch & Lomb plans to buy eye-drug maker Ista Pharmaceuticals Inc. for about $500 million in cash.
The Warsaw, Ind.-based medical device maker won't be prosecuted by the Justice Department if it institutes strict internal controls to prevent bribery.
Irish drug and medical device maker Covidien PLC said it is buying ventilator maker Newport Medical Instruments Inc. for about $108 million.
Members of Congress say these groups are playing a "shell game" — to make money by taking advantage of the drug shortage crisis.
SiO2 Medical Products is investing $90 million in the Alabama plant, which will make products for the biological drugs industry.
Instead of manufacturing drugs using a conventional batch-based system, MIT and Novartis envisioned a continuous manufacturing process, all done in one location, which would cut down on time and cost.
Irish medical device and drug maker agreed to buy Israel-based superDimension Ltd. for about $300 million initially plus possible future payments.
William Weldon, who will step down next month after a decade as CEO, oversaw about 30 product recalls since 2009, which cost about $1 billion.
Illumina's board unanimously turned down Roche's hostile takeover offer last month, saying it was "grossly inadequate."
Drugmakers tout the nerve growth factor inhibitors as a breakthrough for treating chronic pain, but those in previous studies reported bone decay and joint failure.
British experts at the world's biggest artificial joint registry said metal versions have to be fixed or replaced more often than other implants.